Literature DB >> 24412795

X-ray structure and spectroscopy of novel trans-[Ni(L)(NO(3))(2)] and [Ni(L)](ClO(4))(2)·2H(2)O complexes.

Md Abdus Subhan1, Jong-Ha Choi2.   

Abstract

Ni(L)(NO(3))(2) (complex 1) and [Ni(L)](ClO(4))(2)·2H(2)O (complex 2) [L=3,14-diethyl-2,6,13,17-tetraazatricyclo(16.4.0.0(7,12))docosane] have been prepared and structurally characterized by single-crystal X-ray diffraction at 200K. For these constrained macrocycle complexes, nickel(II) exists in a distorted octahedral environment with the four nitrogen atoms of the macrocyclic ligands and two oxygen atoms from nitrate in axial positions in complex 1. The macrocyclic ligand in complex 1 adopts the most stable trans-III conformation. The Ni-N distances in both the complex 1 (2.094(4)-2.051(4)Å) and complex 2 (2.042(8)-1.996(7)Å), are typical but the axial ligands are coordinating, with NiO bond length, 2.198(3)Å for complex 1. The complex 2 adopts square planner geometry around the Ni(II) with four nitrogen atoms from macrocyclic ligand. The crystals are stabilized in a 3-D network by intra and intermolecular hydrogen bonds that are formed among the secondary nitrogen hydrogen atoms and nitrate in 1, and intermolecular hydrogen bonds are formed by perchlorate and NH groups in 2. The electronic absorption, IR and PL spectral properties are also discussed.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Crystal structure; Macrocyclic ligand; Nickel(II); Spectroscopic properties; trans-III Conformation

Mesh:

Substances:

Year:  2013        PMID: 24412795     DOI: 10.1016/j.saa.2013.12.069

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  1 in total

1.  Crystal structure of 3,14-diethyl-2,13-di-aza-6,17-diazo-niatri-cyclo-[16.4.0.07,12]docosane dinitrate dihydrate from synchrotron X-ray data.

Authors:  Dohyun Moon; Sunghwan Jeon; Keon Sang Ryoo; Jong-Ha Choi
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2019-05-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.